S. Jerez, Analía Medina, Gabriela Alarcón, L. Sierra, M. Medina
{"title":"摄入奇亚籽油对预防心血管危险因素有益吗?","authors":"S. Jerez, Analía Medina, Gabriela Alarcón, L. Sierra, M. Medina","doi":"10.3390/blsf2021008007","DOIUrl":null,"url":null,"abstract":"Cold-pressed chia seed oils (ChO) are known for their health-promoting characteristics due to their high content of omega-3 α-linolenic acid (ω-3 ALA). We investigated the influence of ChO supplementation as a functional food on animal models of the cardiovascular risk factors hypercholesterolemia and metabolic syndrome (MS). Dietary intervention with ChO (equivalent to 4.8 g ALA per day) was found to improve vascular dysfunction and mitigate the rise in plasma triglyceride (TG) levels under hypercholesterolemic conditions. However, impaired glucose tolerance was found in control ChO-treated animals. In order to verify whether the effects of chia seed are the same as that of ChO, we replaced ChO with an equivalent amount of seed. Glucose intolerance was found once again. For this reason, we carried out a new study in which ChO intake was reduced to 3 g ALA per day, and no alterations were observed in such conditions. Thus, dietary intervention with ChO equivalent to 3 g ALA intake per day was chosen to analyze the effects on the alterations that characterize high-fat diet-induced MS. ChO supplementation lowered the ω-6/ω-3 ratio, TG, blood pressure and improved endothelial function. Nevertheless, ChO worsened the high-fat diet’s deleterious effects on visceral abdominal fat, fasting glucose and glucose tolerance. Our results support the view that dietary guidelines for treating patients with hypercholesterolemia or MS must be carefully planned in such a way that the incorporation of ChO into the diet should be controlled and nutritional background be considered.","PeriodicalId":400770,"journal":{"name":"Biology and Life Sciences Forum","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Chia Seed Oil Intake: Is It Beneficial for Preventing Cardiovascular Risk Factors?\",\"authors\":\"S. Jerez, Analía Medina, Gabriela Alarcón, L. Sierra, M. Medina\",\"doi\":\"10.3390/blsf2021008007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cold-pressed chia seed oils (ChO) are known for their health-promoting characteristics due to their high content of omega-3 α-linolenic acid (ω-3 ALA). We investigated the influence of ChO supplementation as a functional food on animal models of the cardiovascular risk factors hypercholesterolemia and metabolic syndrome (MS). Dietary intervention with ChO (equivalent to 4.8 g ALA per day) was found to improve vascular dysfunction and mitigate the rise in plasma triglyceride (TG) levels under hypercholesterolemic conditions. However, impaired glucose tolerance was found in control ChO-treated animals. In order to verify whether the effects of chia seed are the same as that of ChO, we replaced ChO with an equivalent amount of seed. Glucose intolerance was found once again. For this reason, we carried out a new study in which ChO intake was reduced to 3 g ALA per day, and no alterations were observed in such conditions. Thus, dietary intervention with ChO equivalent to 3 g ALA intake per day was chosen to analyze the effects on the alterations that characterize high-fat diet-induced MS. ChO supplementation lowered the ω-6/ω-3 ratio, TG, blood pressure and improved endothelial function. Nevertheless, ChO worsened the high-fat diet’s deleterious effects on visceral abdominal fat, fasting glucose and glucose tolerance. Our results support the view that dietary guidelines for treating patients with hypercholesterolemia or MS must be carefully planned in such a way that the incorporation of ChO into the diet should be controlled and nutritional background be considered.\",\"PeriodicalId\":400770,\"journal\":{\"name\":\"Biology and Life Sciences Forum\",\"volume\":\"23 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biology and Life Sciences Forum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/blsf2021008007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biology and Life Sciences Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/blsf2021008007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
冷榨奇亚籽油(ChO)因其高含量的ω-3 α-亚麻酸(ω-3 ALA)而闻名于世。我们研究了作为功能性食品补充ChO对心血管危险因素高胆固醇血症和代谢综合征(MS)动物模型的影响。研究发现,ChO饮食干预(相当于每天4.8 g ALA)可以改善血管功能障碍,减轻高胆固醇血症患者血浆甘油三酯(TG)水平的升高。然而,在对照组动物中发现葡萄糖耐量受损。为了验证奇亚籽与ChO的作用是否相同,我们用等量的籽代替ChO。再次发现葡萄糖耐受不良。出于这个原因,我们进行了一项新的研究,将ChO摄入量减少到每天3g ALA,在这种情况下没有观察到任何变化。因此,我们选择每天摄入相当于3g ALA的ChO作为饮食干预来分析对高脂肪饮食诱导ms的改变的影响,ChO补充降低了ω-6/ω-3比值、TG、血压和改善内皮功能。然而,ChO加重了高脂肪饮食对内脏腹部脂肪、空腹葡萄糖和葡萄糖耐量的有害影响。我们的研究结果支持这样一种观点,即治疗高胆固醇血症或多发性硬化症患者的饮食指南必须仔细规划,以控制ChO在饮食中的掺入,并考虑营养背景。
Chia Seed Oil Intake: Is It Beneficial for Preventing Cardiovascular Risk Factors?
Cold-pressed chia seed oils (ChO) are known for their health-promoting characteristics due to their high content of omega-3 α-linolenic acid (ω-3 ALA). We investigated the influence of ChO supplementation as a functional food on animal models of the cardiovascular risk factors hypercholesterolemia and metabolic syndrome (MS). Dietary intervention with ChO (equivalent to 4.8 g ALA per day) was found to improve vascular dysfunction and mitigate the rise in plasma triglyceride (TG) levels under hypercholesterolemic conditions. However, impaired glucose tolerance was found in control ChO-treated animals. In order to verify whether the effects of chia seed are the same as that of ChO, we replaced ChO with an equivalent amount of seed. Glucose intolerance was found once again. For this reason, we carried out a new study in which ChO intake was reduced to 3 g ALA per day, and no alterations were observed in such conditions. Thus, dietary intervention with ChO equivalent to 3 g ALA intake per day was chosen to analyze the effects on the alterations that characterize high-fat diet-induced MS. ChO supplementation lowered the ω-6/ω-3 ratio, TG, blood pressure and improved endothelial function. Nevertheless, ChO worsened the high-fat diet’s deleterious effects on visceral abdominal fat, fasting glucose and glucose tolerance. Our results support the view that dietary guidelines for treating patients with hypercholesterolemia or MS must be carefully planned in such a way that the incorporation of ChO into the diet should be controlled and nutritional background be considered.